NHS U-turns on Afinitor for TSC-related epilepsyNHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus) for TSC-related refractory epilepsy Share XNHS U-turns on Afinitor for TSC-related epilepsyhttps://pharmaphorum.com/news/nhs-u-turns-afinitor-tsc-related-epilepsy/